Pendred's syndrome
|
0.630 |
GeneticVariation
|
disease |
BEFREE |
Phenotypic analyses and mutation screening of the SLC26A4 and FOXI1 genes in 101 Taiwanese families with bilateral nonsyndromic enlarged vestibular aqueduct (DFNB4) or Pendred syndrome.
|
19648736 |
2010 |
Pendred's syndrome
|
0.630 |
Biomarker
|
disease |
BEFREE |
Together, these data suggest that SLC26A4, FOXI1 and KCNJ10 are not major determinants in unilateral deafness and enlarged vestibular aqueduct compared with their implication in Pendred syndrome and non-syndromic bilateral enlarged vestibular aqueduct.
|
20621367 |
2010 |
Pendred's syndrome
|
0.630 |
GeneticVariation
|
disease |
BEFREE |
We also used this approach to scan for mutations in KCNJ10 and FOXI1, two genes reported to play a role in the pathogenesis of Pendred syndrome and enlarged vestibular aqueduct.
|
21366435 |
2011 |
Cystic Fibrosis
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
Finally, we identified a novel, rare cell type that we call the 'pulmonary ionocyte', which co-expresses FOXI1, multiple subunits of the vacuolar-type H<sup>+</sup>-ATPase (V-ATPase) and CFTR, the gene that is mutated in cystic fibrosis.
|
30069046 |
2018 |
Cystic Fibrosis
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
Knockout of Foxi1 in mouse ionocytes causes loss of Cftr expression and disrupts airway fluid and mucus physiology, phenotypes that are characteristic of cystic fibrosis.
|
30069044 |
2018 |
Congenital Abnormality
|
0.010 |
GeneticVariation
|
group |
BEFREE |
Recently, FOXI1 and KCNJ10 mutations have been linked to enlarged vestibular aqueducts and GJB2 mutations linked to temporal bone malformation.
|
22412181 |
2012 |
Anemia, Hemolytic, Congenital
|
0.010 |
Biomarker
|
disease |
BEFREE |
Additional manifestations include bone demineralization (rickets, osteomalacia), growth deficiency, sensorineural hearing loss (in <i>ATP6V0A4-</i>, <i>ATP6V1B1-</i>, and <i>FOXI1-</i>dRTA), and hereditary hemolytic anemia (in some individuals with <i>SLC4A1-</i>dRTA).
|
31600869 |
2019 |
Renal Cell Carcinoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Chromophobe RCCs express FOXI1-driven genes that define collecting duct intercalated cells, whereas HNF-regulated genes, specific for proximal tubule cells, are an integral part of clear cell and papillary RCC transcriptomes.
|
28793269 |
2017 |
Malignant neoplasm of stomach
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
In conclusion, to the best of our knowledge, our findings are the first to demonstrate that Foxi1 is a key player in the transcriptional control of miR-491-5p and that miR-491-5p acts as an anti-oncogene by targeting Wnt3a/β-catenin signaling in GC.
|
28358374 |
2017 |
Neoplasms
|
0.010 |
Biomarker
|
group |
BEFREE |
miR-491-5p, mediated by Foxi1, functions as a tumor suppressor by targeting Wnt3a/β-catenin signaling in the development of gastric cancer.
|
28358374 |
2017 |
Conventional (Clear Cell) Renal Cell Carcinoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Chromophobe RCCs express FOXI1-driven genes that define collecting duct intercalated cells, whereas HNF-regulated genes, specific for proximal tubule cells, are an integral part of clear cell and papillary RCC transcriptomes.
|
28793269 |
2017 |
Deformity
|
0.010 |
GeneticVariation
|
group |
BEFREE |
Recently, FOXI1 and KCNJ10 mutations have been linked to enlarged vestibular aqueducts and GJB2 mutations linked to temporal bone malformation.
|
22412181 |
2012 |
Oncocytoma, renal
|
0.010 |
Biomarker
|
disease |
BEFREE |
Although the origin of RO remains unclear, our findings suggest that FOXI1 immunohistochemistry is useful in differential diagnosis of RO from chRCC with overlapping histology.
|
31177114 |
2019 |
Congenital diverticulum of pharynx
|
0.010 |
Biomarker
|
disease |
BEFREE |
Foxi1 promotes late-stage pharyngeal pouch morphogenesis through ectodermal Wnt4a activation.
|
29932895 |
2018 |
Stomach Carcinoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
In conclusion, to the best of our knowledge, our findings are the first to demonstrate that Foxi1 is a key player in the transcriptional control of miR-491-5p and that miR-491-5p acts as an anti-oncogene by targeting Wnt3a/β-catenin signaling in GC.
|
28358374 |
2017 |
Chromophobe Renal Cell Carcinoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
Although the origin of RO remains unclear, our findings suggest that FOXI1 immunohistochemistry is useful in differential diagnosis of RO from chRCC with overlapping histology.
|
31177114 |
2019 |
Distal Renal Tubular Acidosis
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Mutations in adenosine triphosphate ATP6V1 (B1 H<sup>+</sup>-ATPase subunit), ATPV0A4 (a4 H<sup>+</sup>-ATPase subunit), SLC4A1 (anion exchanger 1), and FOXI1 (forkhead transcription factor) cause distal renal tubular acidosis type I. Carbonic anhydrase II mutations affect several nephron segments and give rise to a mixed proximal and distal phenotype.
|
31300090 |
2019 |
DEAFNESS, AUTOSOMAL RECESSIVE (disorder)
|
0.010 |
Biomarker
|
disease |
BEFREE |
The FOXI1 gene, which causes autosomal recessive deafness (OMIM 600791, DFNB4) when mutated, was contained within the uniparental isodisomy region (5q34-qter).
|
23824987 |
2013 |
Unilateral deafness
|
0.010 |
Biomarker
|
disease |
BEFREE |
Together, these data suggest that SLC26A4, FOXI1 and KCNJ10 are not major determinants in unilateral deafness and enlarged vestibular aqueduct compared with their implication in Pendred syndrome and non-syndromic bilateral enlarged vestibular aqueduct.
|
20621367 |
2010 |
Pendred's syndrome
|
0.630 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
DEAFNESS, AUTOSOMAL RECESSIVE 4, WITH ENLARGED VESTIBULAR AQUEDUCT
|
0.600 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
Pendred's syndrome
|
0.630 |
Biomarker
|
disease |
CTD_human |
|
|
|
DEAFNESS, AUTOSOMAL RECESSIVE 4, WITH ENLARGED VESTIBULAR AQUEDUCT
|
0.600 |
Biomarker
|
disease |
CTD_human |
|
|
|
Craniofacial Abnormalities
|
0.300 |
Biomarker
|
group |
CTD_human |
A zebrafish screen for craniofacial mutants identifies wdr68 as a highly conserved gene required for endothelin-1 expression.
|
16759393 |
2006 |
Leukemia, Myelocytic, Acute
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
Genome-wide haplotype association study identify the FGFR2 gene as a risk gene for acute myeloid leukemia.
|
27903959 |
2017 |